• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cell surface hyaluronidase (TMEM2), Truncated

ACP02501

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02501 Target NameTMEM2
Target SynonymsKIAA1412; TMEM 2; tmem2; TMEM2_HUMAN; Transmembrane protein 2FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range104-250aa
Mol Weight21.5 kDaProtein LengthPartial
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9UHN6
Background Information
  • Uniprot Id

    Q9UHN6

  • Target Species

    Human

  • Target Name

    CEMIP2

  • Target Full Name

    Cell surface hyaluronidase CEMIP2

  • Target Function

    Unlike its mouse ortholog has no catalytic hyaluronic acid-degrading activity, but acts as a regulator of hyaluronan (HA) metabolism through regulation of expression of CEMIP and HAS2, two enzymes involved in HA depolymerization and HA synthesis, respectively.

  • Target Subcellular Location

    Cell membrane; Single-pass type II membrane protein.

  • Target Protein Families

    TMEM2 family

  • Target Tissue Specificity

    Widely expressed.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    KIAA1412; TMEM 2; tmem2; TMEM2_HUMAN; Transmembrane protein 2

  • Target Background

    This gene encodes a type II transmembrane protein that belongs to the interferon-induced transmembrane (IFITM) protein superfamily. The encoded protein functions as a cell surface hyaluronidase that cleaves extracellular high molecular weight hyaluronan into intermediate size fragments before internalization and degradation in the lysosome. It also has an interferon-mediated antiviral function in humans through activation of the JAK STAT signaling pathway. The activation of this gene by transcription factor SOX4 in breast cancer cells has been shown to mediate the pathological effects of SOX4 on cancer progression. Naturally occurring mutations in this gene are associated with autosomal recessive non-syndromic hearing loss.

Inquire Recombinant Human Cell surface hyaluronidase (TMEM2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification